These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 8854402)

  • 21. Identification of genomic responses to collagen binding by trophozoites of Entamoeba histolytica.
    Debnath A; Das P; Sajid M; McKerrow JH
    J Infect Dis; 2004 Aug; 190(3):448-57. PubMed ID: 15243916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of molecular tools to distinguish Entamoeba histolytica and Entamoeba dispar infection among the aborigines in Cameron Highlands.
    Noor Azian MY; Lokman Hakim S; Maslawaty MN
    Trop Biomed; 2006 Jun; 23(1):31-6. PubMed ID: 17041549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity of clinical isolates of Entamoeba histolytica in Japan.
    Nozaki T; Kobayashi S; Takeuchi T; Haghighi A
    Arch Med Res; 2006 Feb; 37(2):277-9. PubMed ID: 16380332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the redefinition of the agent of amoebiasis.
    Lucas R; Upcroft JA
    Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of hexokinase isoenzyme typing and antigen detection for differentiation of Entamoeba histolytica and Entamoeba dispar.
    Bansal D; Sehgal R; Chawla Y; Mahajan RC; Malla N
    Nepal Med Coll J; 2004 Dec; 6(2):123-5. PubMed ID: 16295743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Entamoeba sp. strain isolated from rhesus monkey is virulent but genetically different from Entamoeba histolytica.
    Tachibana H; Yanagi T; Pandey K; Cheng XJ; Kobayashi S; Sherchand JB; Kanbara H
    Mol Biochem Parasitol; 2007 Jun; 153(2):107-14. PubMed ID: 17403547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
    Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H
    PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Distinguishing between pathogenic and nonpathogenic isolates of Entamoeba histolytica by polymerase chain reaction].
    Tachibana H
    Nihon Rinsho; 1992 Jul; 50 Suppl():448-52. PubMed ID: 1404938
    [No Abstract]   [Full Text] [Related]  

  • 29. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of autophagy in the enteric protozoan parasite Entamoeba.
    Picazarri K; Nakada-Tsukui K; Sato D; Nozaki T
    Methods Enzymol; 2008; 451():359-71. PubMed ID: 19185732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the polymerase chain reaction (PCR) in the epidemiology of Entamoeba histolytica and Entamoeba dispar infections.
    Rivera WL; Tachibana H; Kanbara H
    Tokai J Exp Clin Med; 1998 Dec; 23(6):413-5. PubMed ID: 10622639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A family of transcripts (K2) of Entamoeba histolytica contains polymorphic repetitive regions with highly conserved elements.
    Köhler S; Tannich E
    Mol Biochem Parasitol; 1993 May; 59(1):49-58. PubMed ID: 8515783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular biology in the differentiation between pathogenic and apathogenic isolates of Entamoeba histolytica].
    Tannich E; Burchard GD; Arnold HH
    Z Gastroenterol Verh; 1990 Apr; 25():71-4. PubMed ID: 1694369
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in morphology of phagosomes and kinetics of acidification and degradation in phagosomes between the pathogenic Entamoeba histolytica and the non-pathogenic Entamoeba dispar.
    Mitra BN; Yasuda T; Kobayashi S; Saito-Nakano Y; Nozaki T
    Cell Motil Cytoskeleton; 2005 Oct; 62(2):84-99. PubMed ID: 16106449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Entamoeba histolytica: a snapshot of current research and methods for genetic analysis.
    Morf L; Singh U
    Curr Opin Microbiol; 2012 Aug; 15(4):469-75. PubMed ID: 22664276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.
    Lejeune M; Rybicka JM; Chadee K
    Future Microbiol; 2009 Feb; 4(1):105-18. PubMed ID: 19207103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new gene family (ariel) encodes asparagine-rich Entamoeba histolytica antigens, which resemble the amebic vaccine candidate serine-rich E. histolytica protein.
    Mai Z; Samuelson J
    Infect Immun; 1998 Jan; 66(1):353-5. PubMed ID: 9423879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique cysteine proteinase gene of pathogenic Entamoeba histolytica correlates with virulence.
    Reed S; Bouvier J; Hirata K; Que X; Pollack AS; Engel JC; Gillin F; McKerrow JH
    Arch Med Res; 1992; 23(2):181-2. PubMed ID: 1340288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into Entamoeba histolytica pathogenesis.
    Baxt LA; Singh U
    Curr Opin Infect Dis; 2008 Oct; 21(5):489-94. PubMed ID: 18725798
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Ng YL; Olivos-García A; Lim TK; Noordin R; Lin Q; Othman N
    Am J Trop Med Hyg; 2018 Dec; 99(6):1518-1529. PubMed ID: 30298805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.